Temporary mechanical circulatory support in fulminant myocarditis: can global collaborations bridge the gap?

• by Aidan J. C. Burrell, Patrick R. Lawler, Ary Serpa Neto

• June 11, 2026

Long-term efficacy and renal safety of SGLT2 inhibitors in patients with heart failure and advanced chronic kidney disease (stage 4): a propensity score-matched retrospective cohort study

• by Weihua Peng, Xiaoke Shang, Changdong Zhang, Mei Liu

• June 17, 2026

Prediction model for early left ventricular systolic dysfunction progression in hypertrophic cardiomyopathy

• by Yu Li, Ziqi Duan, Jinlei Li, Bingxin Cheng, Fen Ai, Zhen Chen

• June 12, 2026

How Quickly Are Patients Reaching Quadruple HFrEF Therapy?

Delays in initiating guideline-directed quadruple therapy may increase early clinical risk in heart failure with reduced ejection fraction.

• by Kathryn Wighton

• June 8, 2026

• 5 min